The CME Group of the International Derivatives announced today that the volume of transactions in its investment grade and high -performance future contracts exceeded 450,000 contracts, as open interest (OI) reached 6,800 contracts on September 4.
“With US credit fields close to historically low, customers are looking for new sources of liquidity to help them mitigate credit risk accurately and effectively,” said Agha Mirza, CME Global Chead of Remeing and OTC Products. “As uncertainty continues in all markets, our future future provides customers with a cost -effective compensation solution for corporate bond indicators, with automatic marginal offenses available against future shares and future shares.”
CME Group Credit Fortures are the first future fulfillment contracts to help market participants manage the risk of duration by spreading future future US fulfillment. Automatic marginal offenses against the CME Group interest rate and future shares are part of the daily efficiency of 60 billion dollars that the company delivers to customers in asset courses.
Contracts launched in June 2024 and are based on Bloomberg US Corporate Bond Indicators, allowing investors to browse the exposure to one of the largest and most wetting fixed income markets in the world.
Available for trade in CME Globex and is eligible for submission for clearing via CME Clearport, CME Group Credit Futures are listed with and subject to CBOT rules.